Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.

MLA

Parise, Robert A., et al. “Formation of Active Products of Benzaldehyde Dimethane Sulfonate (NSC 281612, DMS612) in Human Blood and Plasma and Their Activity against Renal Cell Carcinoma Lines.” Cancer Chemotherapy and Pharmacology, vol. 71, no. 1, Jan. 2013, pp. 73–83. EBSCOhost, https://doi.org/10.1007/s00280-012-1980-1.

APA

Parise, R. A., Anyang, B. N., Eiseman, J. L., Egorin, M. J., Covey, J. M., & Beumer, J. H. (2013). Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines. Cancer Chemotherapy and Pharmacology, 71(1), 73–83. https://doi.org/10.1007/s00280-012-1980-1

Chicago

Parise, Robert A, Bean N Anyang, Julie L Eiseman, Merrill J Egorin, Joseph M Covey, and Jan H Beumer. 2013. “Formation of Active Products of Benzaldehyde Dimethane Sulfonate (NSC 281612, DMS612) in Human Blood and Plasma and Their Activity against Renal Cell Carcinoma Lines.” Cancer Chemotherapy and Pharmacology 71 (1): 73–83. doi:10.1007/s00280-012-1980-1.